Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
AstraZeneca recently announced plans to outsource its entire drug manufacturing activities within 10 years. David Smith, the company’s executive vice president of operations, was quoted in The New York Times as saying, “Manufacturing for AstraZeneca is not a core activity. AstraZeneca is about innovation and brandbuilding . . .
